Fig. 2From: Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMedâ„¢ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fastingAHCL system performance showing glucose control between vildagliptin and control groups at baseline and at the end of Ramadan among the enrolled patients with type 1 diabetes on MiniMedâ„¢ 780G. Glucose values are shown as percentage of time spent in ranges during the study periodBack to article page